| Entity Name: | Meridian Clinical Research |
| Jurisdiction: | Connecticut |
| Legal type: | Stock |
| Citizenship: | Foreign |
| Status: | Rejected |
| Date Formed: | 09 Jul 2021 (Companies founded in July 2021) |
| Business ALEI: | 2299779 |
| NAICS code: | 541714 - Research and Development in Biotechnology (except Nanobiotechnology) |
| Business address: | 3319 N 107th Street, Omaha, NE, 68134, United States |
| Mailing address: | 1230 Aries Drive Suite A, Lincoln, NE, United States, 68512 |
| Place of Formation: | NEBRASKA |
| E-Mail: | awindle@spgrouppc.com |
| Name | Role | Business address | Residence address |
|---|---|---|---|
| Dave Roehr | Officer | 3319 N 107th Street, Omaha, NE, 68134, United States | 5100 Bentley Dr, Lincoln, NE, 68516-9269, United States |
| Name | Role | Business address | Residence address |
|---|---|---|---|
| Nicole Osborn | Director | 3319 N 107th Street, Omaha, NE, 68134, United States | 21809 Marinda St, Elkhorn, NE, 68022-2874, United States |
| Name | Role |
|---|---|
| Meridian Clinical Research | Agent |
Date of last update: 11 Nov 2024
Sources: Connecticut's Official State Website
